

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | urate metabolic process (GO:0046415) | 9.30606980 |
| 2 | aminoglycoside antibiotic metabolic process (GO:0030647) | 9.13930491 |
| 3 | drug transmembrane transport (GO:0006855) | 9.07226772 |
| 4 | lysine metabolic process (GO:0006553) | 8.24546431 |
| 5 | lysine catabolic process (GO:0006554) | 8.24546431 |
| 6 | drug transport (GO:0015893) | 7.76125908 |
| 7 | organic cation transport (GO:0015695) | 7.64627927 |
| 8 | response to mercury ion (GO:0046689) | 7.59245158 |
| 9 | phosphate ion transport (GO:0006817) | 7.55597366 |
| 10 | excretion (GO:0007588) | 7.52459425 |
| 11 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 6.84317693 |
| 12 | renal absorption (GO:0070293) | 6.81466787 |
| 13 | metanephric tubule development (GO:0072170) | 6.74979237 |
| 14 | metanephric nephron tubule development (GO:0072234) | 6.74979237 |
| 15 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 6.63864923 |
| 16 | cardiovascular system development (GO:0072358) | 6.40757168 |
| 17 | negative regulation of metanephros development (GO:0072217) | 6.37539893 |
| 18 | metanephric nephron epithelium development (GO:0072243) | 6.35890404 |
| 19 | phosphate ion transmembrane transport (GO:0035435) | 6.30738997 |
| 20 | quaternary ammonium group transport (GO:0015697) | 6.26107320 |
| 21 | glyoxylate metabolic process (GO:0046487) | 6.02372257 |
| 22 | cysteine metabolic process (GO:0006534) | 5.90186392 |
| 23 | metanephric epithelium development (GO:0072207) | 5.87672609 |
| 24 | polyol transport (GO:0015791) | 5.71350180 |
| 25 | negative regulation of cholesterol transport (GO:0032375) | 5.70313984 |
| 26 | negative regulation of sterol transport (GO:0032372) | 5.70313984 |
| 27 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 5.70310387 |
| 28 | tricarboxylic acid metabolic process (GO:0072350) | 5.68265497 |
| 29 | response to water (GO:0009415) | 5.56614672 |
| 30 | aspartate family amino acid catabolic process (GO:0009068) | 5.56523404 |
| 31 | vitamin D metabolic process (GO:0042359) | 5.38760240 |
| 32 | pattern specification involved in kidney development (GO:0061004) | 5.30763027 |
| 33 | drug catabolic process (GO:0042737) | 5.24910102 |
| 34 | nephron tubule development (GO:0072080) | 5.07834528 |
| 35 | nonribosomal peptide biosynthetic process (GO:0019184) | 5.06629708 |
| 36 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 5.06521713 |
| 37 | short-chain fatty acid metabolic process (GO:0046459) | 5.04459673 |
| 38 | response to thyroid hormone (GO:0097066) | 4.97091211 |
| 39 | exogenous drug catabolic process (GO:0042738) | 4.95607710 |
| 40 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 4.91753976 |
| 41 | branched-chain amino acid metabolic process (GO:0009081) | 4.89117309 |
| 42 | positive regulation of catenin import into nucleus (GO:0035413) | 4.83105099 |
| 43 | toxin transport (GO:1901998) | 4.76755882 |
| 44 | valine metabolic process (GO:0006573) | 4.71560819 |
| 45 | amino-acid betaine transport (GO:0015838) | 4.69010650 |
| 46 | carnitine transport (GO:0015879) | 4.69010650 |
| 47 | 2-oxoglutarate metabolic process (GO:0006103) | 4.66211357 |
| 48 | phosphate ion homeostasis (GO:0055062) | 4.62981034 |
| 49 | trivalent inorganic anion homeostasis (GO:0072506) | 4.62981034 |
| 50 | homocysteine metabolic process (GO:0050667) | 4.62353416 |
| 51 | glutathione biosynthetic process (GO:0006750) | 4.55643890 |
| 52 | renal tubule development (GO:0061326) | 4.50048308 |
| 53 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 4.43851100 |
| 54 | modified amino acid transport (GO:0072337) | 4.43053763 |
| 55 | response to parathyroid hormone (GO:0071107) | 4.42697847 |
| 56 | tryptophan catabolic process (GO:0006569) | 4.37707048 |
| 57 | indole-containing compound catabolic process (GO:0042436) | 4.37707048 |
| 58 | indolalkylamine catabolic process (GO:0046218) | 4.37707048 |
| 59 | hyperosmotic response (GO:0006972) | 4.36855315 |
| 60 | aromatic amino acid family catabolic process (GO:0009074) | 4.35712590 |
| 61 | activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171) | 4.34413735 |
| 62 | thyroid hormone generation (GO:0006590) | 4.31598896 |
| 63 | L-phenylalanine metabolic process (GO:0006558) | 4.30592470 |
| 64 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.30592470 |
| 65 | nephron epithelium development (GO:0072009) | 4.25093534 |
| 66 | cellular modified amino acid catabolic process (GO:0042219) | 4.22837448 |
| 67 | collecting duct development (GO:0072044) | 4.21065657 |
| 68 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.19958823 |
| 69 | L-phenylalanine catabolic process (GO:0006559) | 4.19958823 |
| 70 | amino-acid betaine metabolic process (GO:0006577) | 4.17757745 |
| 71 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.16024424 |
| 72 | glycoside metabolic process (GO:0016137) | 4.13413735 |
| 73 | fatty acid beta-oxidation (GO:0006635) | 4.11985033 |
| 74 | branched-chain amino acid catabolic process (GO:0009083) | 4.11622029 |
| 75 | tryptophan metabolic process (GO:0006568) | 4.11616468 |
| 76 | proline metabolic process (GO:0006560) | 4.10966432 |
| 77 | cell differentiation involved in metanephros development (GO:0072202) | 4.06290787 |
| 78 | response to copper ion (GO:0046688) | 4.03599897 |
| 79 | gamma-aminobutyric acid transport (GO:0015812) | 3.98811039 |
| 80 | serine family amino acid catabolic process (GO:0009071) | 3.96986987 |
| 81 | inositol metabolic process (GO:0006020) | 3.96519627 |
| 82 | response to magnesium ion (GO:0032026) | 3.96426630 |
| 83 | serine family amino acid metabolic process (GO:0009069) | 3.95356069 |
| 84 | regulation of nephron tubule epithelial cell differentiation (GO:0072182) | 3.95224307 |
| 85 | cellular ketone body metabolic process (GO:0046950) | 3.93422533 |
| 86 | mesonephros development (GO:0001823) | 3.93241201 |
| 87 | urogenital system development (GO:0001655) | 3.89587423 |
| 88 | peptide catabolic process (GO:0043171) | 3.88282397 |
| 89 | acetyl-CoA metabolic process (GO:0006084) | 3.87671795 |
| 90 | NADH metabolic process (GO:0006734) | 3.85654016 |
| 91 | regulation of mesenchymal cell apoptotic process (GO:2001053) | 3.83920319 |
| 92 | fructose metabolic process (GO:0006000) | 3.83628875 |
| 93 | fatty acid oxidation (GO:0019395) | 3.81467214 |
| 94 | carnitine metabolic process (GO:0009437) | 3.80232769 |
| 95 | response to vitamin A (GO:0033189) | 3.76663635 |
| 96 | glutamate metabolic process (GO:0006536) | 3.74892466 |
| 97 | lipid oxidation (GO:0034440) | 3.74679126 |
| 98 | renal system process (GO:0003014) | 3.72576894 |
| 99 | regulation of stem cell maintenance (GO:2000036) | 3.68242766 |
| 100 | bone remodeling (GO:0046849) | 3.67348328 |
| 101 | kynurenine metabolic process (GO:0070189) | 3.66952550 |
| 102 | peptide biosynthetic process (GO:0043043) | 3.62095004 |
| 103 | flavonoid metabolic process (GO:0009812) | 3.55129369 |
| 104 | mammary gland alveolus development (GO:0060749) | 3.54356626 |
| 105 | nephron tubule morphogenesis (GO:0072078) | 3.54315798 |
| 106 | nephron epithelium morphogenesis (GO:0072088) | 3.54315798 |
| 107 | cell volume homeostasis (GO:0006884) | 3.54161769 |
| 108 | positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190) | 3.53010061 |
| 109 | actin filament depolymerization (GO:0030042) | 3.52031928 |
| 110 | regulation of protein localization to cell surface (GO:2000008) | 3.51815739 |
| 111 | beta-amyloid metabolic process (GO:0050435) | 3.50456881 |
| 112 | sodium-independent organic anion transport (GO:0043252) | 3.50419947 |
| 113 | cellular response to vitamin D (GO:0071305) | 3.49221887 |
| 114 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.47668400 |
| 115 | response to lead ion (GO:0010288) | 3.47466122 |
| 116 | response to growth hormone (GO:0060416) | 3.47451519 |
| 117 | response to phenylpropanoid (GO:0080184) | 3.45355947 |
| 118 | negative regulation of kidney development (GO:0090185) | 3.44475068 |
| 119 | tricarboxylic acid cycle (GO:0006099) | 3.44288936 |
| 120 | sulfur compound transport (GO:0072348) | 3.44215146 |
| 121 | positive regulation of cellular amine metabolic process (GO:0033240) | 3.44047308 |
| 122 | regulation of epithelial cell differentiation involved in kidney development (GO:2000696) | 3.43376896 |
| 123 | vitamin transport (GO:0051180) | 3.40290394 |
| 124 | ERK1 and ERK2 cascade (GO:0070371) | 3.39758705 |
| 125 | cellular response to ammonium ion (GO:0071242) | 3.39460313 |
| 126 | regulation of branching involved in ureteric bud morphogenesis (GO:0090189) | 3.38248311 |
| 127 | cellular amino acid catabolic process (GO:0009063) | 3.37743457 |
| 128 | ketone body metabolic process (GO:1902224) | 3.36959812 |
| 129 | thyroid hormone metabolic process (GO:0042403) | 3.35892553 |
| 130 | fatty acid catabolic process (GO:0009062) | 3.35429190 |
| 131 | positive regulation of metanephros development (GO:0072216) | 3.33469137 |
| 132 | sodium ion transport (GO:0006814) | 3.32006608 |
| 133 | surfactant homeostasis (GO:0043129) | 3.28842074 |
| 134 | positive regulation of hormone metabolic process (GO:0032352) | 3.28175010 |
| 135 | glomerular visceral epithelial cell development (GO:0072015) | 3.27574593 |
| 136 | hyperosmotic salinity response (GO:0042538) | 3.26526506 |
| 137 | alpha-amino acid catabolic process (GO:1901606) | 3.25750685 |
| 138 | mesenchymal to epithelial transition (GO:0060231) | 3.23509036 |
| 139 | biotin metabolic process (GO:0006768) | 3.21074654 |
| 140 | oxaloacetate metabolic process (GO:0006107) | 3.20081247 |
| 141 | glutathione metabolic process (GO:0006749) | 3.20054175 |
| 142 | glutathione derivative metabolic process (GO:1901685) | 3.18983967 |
| 143 | glutathione derivative biosynthetic process (GO:1901687) | 3.18983967 |
| 144 | nephron tubule formation (GO:0072079) | 3.18980914 |
| 145 | aromatic amino acid family metabolic process (GO:0009072) | 3.18802257 |
| 146 | sulfur amino acid catabolic process (GO:0000098) | 3.17807130 |
| 147 | cellular hyperosmotic response (GO:0071474) | 3.16043808 |
| 148 | specification of organ identity (GO:0010092) | 3.15997949 |
| 149 | cellular glucuronidation (GO:0052695) | 3.11233201 |
| 150 | positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742) | 3.09032312 |
| 151 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 3.07921255 |
| 152 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 3.07921255 |
| 153 | response to salt stress (GO:0009651) | 3.07512074 |
| 154 | glycine metabolic process (GO:0006544) | 3.03196304 |
| 155 | sulfate transmembrane transport (GO:1902358) | 3.02938353 |
| 156 | positive regulation of glomerulus development (GO:0090193) | 2.99759220 |
| 157 | negative regulation of lipid transport (GO:0032369) | 2.99291031 |
| 158 | glucuronate metabolic process (GO:0019585) | 2.96899970 |
| 159 | uronic acid metabolic process (GO:0006063) | 2.96899970 |
| 160 | positive regulation of mesonephros development (GO:0061213) | 2.91529206 |
| 161 | metanephric mesenchyme development (GO:0072075) | 2.90993143 |
| 162 | L-methionine biosynthetic process (GO:0071265) | 2.89307071 |
| 163 | amino acid salvage (GO:0043102) | 2.89307071 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.51588354 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.60642838 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.30759054 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.90649248 |
| 5 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.87379308 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.47984212 |
| 7 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.96936632 |
| 8 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.91321091 |
| 9 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.88246207 |
| 10 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.78632815 |
| 11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.76987900 |
| 12 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.76249207 |
| 13 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.70470937 |
| 14 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.56395240 |
| 15 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.48881444 |
| 16 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.47961946 |
| 17 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.21727377 |
| 18 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.07146626 |
| 19 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.06101080 |
| 20 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.91739421 |
| 21 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.77747376 |
| 22 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.75796690 |
| 23 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.74458354 |
| 24 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.72655316 |
| 25 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.72605099 |
| 26 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.72009281 |
| 27 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.69960263 |
| 28 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.68737064 |
| 29 | VDR_22108803_ChIP-Seq_LS180_Human | 1.62052390 |
| 30 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.61027259 |
| 31 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.60250824 |
| 32 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.52945429 |
| 33 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.51290307 |
| 34 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.47201330 |
| 35 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.46752070 |
| 36 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.40481415 |
| 37 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.38083976 |
| 38 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.37500646 |
| 39 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.37223364 |
| 40 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.35012474 |
| 41 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.34205365 |
| 42 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.29733526 |
| 43 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.28675719 |
| 44 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.28377313 |
| 45 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.28224874 |
| 46 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.28189905 |
| 47 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.27412981 |
| 48 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.26484758 |
| 49 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.26086703 |
| 50 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.26026768 |
| 51 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.25018210 |
| 52 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.21597534 |
| 53 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.21597534 |
| 54 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.20825434 |
| 55 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.20798801 |
| 56 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.20763841 |
| 57 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.20552478 |
| 58 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.19806756 |
| 59 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.19577690 |
| 60 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.17074890 |
| 61 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.16617176 |
| 62 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.15685051 |
| 63 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.15563674 |
| 64 | RXR_22108803_ChIP-Seq_LS180_Human | 1.15330389 |
| 65 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.14798083 |
| 66 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.14798083 |
| 67 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.13997875 |
| 68 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.12951510 |
| 69 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.10298338 |
| 70 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.08446657 |
| 71 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.08247752 |
| 72 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07989994 |
| 73 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.07699423 |
| 74 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.07674195 |
| 75 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.07221775 |
| 76 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.06733381 |
| 77 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.06700797 |
| 78 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.06023674 |
| 79 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.05922670 |
| 80 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.05505364 |
| 81 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.03320348 |
| 82 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.02596524 |
| 83 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.02001195 |
| 84 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99985187 |
| 85 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.99972316 |
| 86 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.99061662 |
| 87 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.99045138 |
| 88 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.98686271 |
| 89 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.98581245 |
| 90 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.98552924 |
| 91 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.98506590 |
| 92 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.98127436 |
| 93 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.97221437 |
| 94 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.96260711 |
| 95 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.95836385 |
| 96 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.94714584 |
| 97 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.93398530 |
| 98 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.92172869 |
| 99 | ATF3_27146783_Chip-Seq_COLON_Human | 0.92021947 |
| 100 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.90809440 |
| 101 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.90742904 |
| 102 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.90566140 |
| 103 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.90561660 |
| 104 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.89841826 |
| 105 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.89263638 |
| 106 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.88286417 |
| 107 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.88034864 |
| 108 | CBP_21632823_ChIP-Seq_H3396_Human | 0.87951926 |
| 109 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.87795631 |
| 110 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.87736405 |
| 111 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.87696637 |
| 112 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87492204 |
| 113 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.87161710 |
| 114 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.87018887 |
| 115 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.86884130 |
| 116 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.86866442 |
| 117 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.86295180 |
| 118 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.85554536 |
| 119 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.85544701 |
| 120 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.85441842 |
| 121 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.84403223 |
| 122 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.84328845 |
| 123 | CJUN_26792858_Chip-Seq_BT549_Human | 0.82835624 |
| 124 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.82675360 |
| 125 | * P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.82497622 |
| 126 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.82485308 |
| 127 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.81355277 |
| 128 | KDM2B_26808549_Chip-Seq_K562_Human | 0.81140600 |
| 129 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.80820033 |
| 130 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.80309022 |
| 131 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.80277400 |
| 132 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.79187375 |
| 133 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.78843532 |
| 134 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.77047270 |
| 135 | GATA2_19941826_ChIP-Seq_K562_Human | 0.76635129 |
| 136 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.76383446 |
| 137 | * SOX11_22085726_ChIP-Seq_ESNs_Mouse | 0.76153582 |
| 138 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.75690816 |
| 139 | P68_20966046_ChIP-Seq_HELA_Human | 0.75551175 |
| 140 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.74600550 |
| 141 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.74319339 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004043_abnormal_pH_regulation | 7.87976116 |
| 2 | MP0005360_urolithiasis | 6.61650950 |
| 3 | MP0003195_calcinosis | 5.42013648 |
| 4 | MP0005332_abnormal_amino_acid | 4.55607591 |
| 5 | MP0004019_abnormal_vitamin_homeostasis | 4.40549423 |
| 6 | MP0009643_abnormal_urine_homeostasis | 4.10787459 |
| 7 | MP0001756_abnormal_urination | 4.05180434 |
| 8 | MP0001765_abnormal_ion_homeostasis | 3.92555700 |
| 9 | MP0002138_abnormal_hepatobiliary_system | 3.90520989 |
| 10 | MP0002139_abnormal_hepatobiliary_system | 3.84567039 |
| 11 | MP0002136_abnormal_kidney_physiology | 3.15852620 |
| 12 | MP0005636_abnormal_mineral_homeostasis | 3.14397708 |
| 13 | MP0003878_abnormal_ear_physiology | 2.67376471 |
| 14 | MP0005377_hearing/vestibular/ear_phenot | 2.67376471 |
| 15 | MP0001958_emphysema | 2.52325646 |
| 16 | MP0003252_abnormal_bile_duct | 2.44923642 |
| 17 | MP0008875_abnormal_xenobiotic_pharmacok | 2.31029304 |
| 18 | MP0008961_abnormal_basal_metabolism | 2.00711403 |
| 19 | MP0000538_abnormal_urinary_bladder | 1.95975785 |
| 20 | MP0005058_abnormal_lysosome_morphology | 1.90644990 |
| 21 | MP0005365_abnormal_bile_salt | 1.83013929 |
| 22 | MP0004885_abnormal_endolymph | 1.82998268 |
| 23 | MP0005085_abnormal_gallbladder_physiolo | 1.60723860 |
| 24 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.53534819 |
| 25 | MP0003300_gastrointestinal_ulcer | 1.48742980 |
| 26 | MP0002168_other_aberrant_phenotype | 1.47655669 |
| 27 | MP0003186_abnormal_redox_activity | 1.43951669 |
| 28 | MP0002928_abnormal_bile_duct | 1.39646143 |
| 29 | MP0002135_abnormal_kidney_morphology | 1.29672616 |
| 30 | MP0005084_abnormal_gallbladder_morpholo | 1.28806596 |
| 31 | MP0002876_abnormal_thyroid_physiology | 1.26982418 |
| 32 | MP0003183_abnormal_peptide_metabolism | 1.25083925 |
| 33 | MP0005451_abnormal_body_composition | 1.24966491 |
| 34 | MP0000230_abnormal_systemic_arterial | 1.24179193 |
| 35 | MP0010234_abnormal_vibrissa_follicle | 1.24128371 |
| 36 | MP0005319_abnormal_enzyme/_coenzyme | 1.17883203 |
| 37 | MP0003283_abnormal_digestive_organ | 1.12807591 |
| 38 | MP0006036_abnormal_mitochondrial_physio | 1.08444512 |
| 39 | MP0002896_abnormal_bone_mineralization | 1.05364445 |
| 40 | MP0005083_abnormal_biliary_tract | 1.04459654 |
| 41 | MP0000534_abnormal_ureter_morphology | 1.01700960 |
| 42 | MP0003191_abnormal_cellular_cholesterol | 0.92806027 |
| 43 | MP0005535_abnormal_body_temperature | 0.90095086 |
| 44 | MP0003806_abnormal_nucleotide_metabolis | 0.89587780 |
| 45 | MP0005666_abnormal_adipose_tissue | 0.89315089 |
| 46 | MP0000678_abnormal_parathyroid_gland | 0.89137785 |
| 47 | MP0004264_abnormal_extraembryonic_tissu | 0.83140282 |
| 48 | MP0005670_abnormal_white_adipose | 0.82531183 |
| 49 | MP0004272_abnormal_basement_membrane | 0.81765866 |
| 50 | MP0003638_abnormal_response/metabolism_ | 0.80748015 |
| 51 | MP0003943_abnormal_hepatobiliary_system | 0.80541175 |
| 52 | MP0009672_abnormal_birth_weight | 0.79051100 |
| 53 | MP0001666_abnormal_nutrient_absorption | 0.78743476 |
| 54 | MP0002089_abnormal_postnatal_growth/wei | 0.77181471 |
| 55 | MP0002796_impaired_skin_barrier | 0.77007460 |
| 56 | MP0001764_abnormal_homeostasis | 0.74936934 |
| 57 | MP0010368_abnormal_lymphatic_system | 0.74782536 |
| 58 | MP0005220_abnormal_exocrine_pancreas | 0.73885415 |
| 59 | MP0005395_other_phenotype | 0.73598811 |
| 60 | MP0003172_abnormal_lysosome_physiology | 0.73279431 |
| 61 | MP0003045_fibrosis | 0.73111560 |
| 62 | MP0002118_abnormal_lipid_homeostasis | 0.72410567 |
| 63 | MP0009642_abnormal_blood_homeostasis | 0.69123775 |
| 64 | MP0000747_muscle_weakness | 0.68024102 |
| 65 | MP0003959_abnormal_lean_body | 0.65339692 |
| 66 | MP0003646_muscle_fatigue | 0.61446027 |
| 67 | MP0008004_abnormal_stomach_pH | 0.59972023 |
| 68 | MP0010386_abnormal_urinary_bladder | 0.59352057 |
| 69 | MP0001270_distended_abdomen | 0.58295972 |
| 70 | MP0003938_abnormal_ear_development | 0.57483085 |
| 71 | MP0001661_extended_life_span | 0.57270747 |
| 72 | MP0000566_synostosis | 0.56648599 |
| 73 | MP0004147_increased_porphyrin_level | 0.56200743 |
| 74 | MP0005165_increased_susceptibility_to | 0.56126868 |
| 75 | MP0009764_decreased_sensitivity_to | 0.53863683 |
| 76 | MP0008872_abnormal_physiological_respon | 0.53622395 |
| 77 | MP0005501_abnormal_skin_physiology | 0.52413119 |
| 78 | MP0003795_abnormal_bone_structure | 0.49799559 |
| 79 | MP0005167_abnormal_blood-brain_barrier | 0.49018018 |
| 80 | MP0002971_abnormal_brown_adipose | 0.48924597 |
| 81 | MP0000609_abnormal_liver_physiology | 0.47964989 |
| 82 | MP0001944_abnormal_pancreas_morphology | 0.47467374 |
| 83 | MP0004742_abnormal_vestibular_system | 0.46777868 |
| 84 | MP0001963_abnormal_hearing_physiology | 0.46501786 |
| 85 | MP0002115_abnormal_skeleton_extremities | 0.46297511 |
| 86 | MP0000026_abnormal_inner_ear | 0.45520859 |
| 87 | MP0004858_abnormal_nervous_system | 0.43370028 |
| 88 | MP0003329_amyloid_beta_deposits | 0.43240382 |
| 89 | MP0001731_abnormal_postnatal_growth | 0.42609801 |
| 90 | MP0002098_abnormal_vibrissa_morphology | 0.42387453 |
| 91 | MP0003879_abnormal_hair_cell | 0.42147525 |
| 92 | MP0000681_abnormal_thyroid_gland | 0.42064566 |
| 93 | MP0000598_abnormal_liver_morphology | 0.41774812 |
| 94 | MP0010329_abnormal_lipoprotein_level | 0.41157817 |
| 95 | MP0005375_adipose_tissue_phenotype | 0.40911745 |
| 96 | MP0005408_hypopigmentation | 0.40781926 |
| 97 | MP0004233_abnormal_muscle_weight | 0.40578801 |
| 98 | MP0008469_abnormal_protein_level | 0.40270551 |
| 99 | MP0002069_abnormal_eating/drinking_beha | 0.40164624 |
| 100 | MP0003941_abnormal_skin_development | 0.39899366 |
| 101 | MP0003953_abnormal_hormone_level | 0.39163321 |
| 102 | MP0000163_abnormal_cartilage_morphology | 0.39022282 |
| 103 | MP0002998_abnormal_bone_remodeling | 0.38793044 |
| 104 | MP0001177_atelectasis | 0.37967608 |
| 105 | MP0003942_abnormal_urinary_system | 0.37633936 |
| 106 | MP0001191_abnormal_skin_condition | 0.37412240 |
| 107 | MP0000383_abnormal_hair_follicle | 0.37243271 |
| 108 | MP0000920_abnormal_myelination | 0.37187968 |
| 109 | MP0003315_abnormal_perineum_morphology | 0.36693006 |
| 110 | MP0010678_abnormal_skin_adnexa | 0.35918242 |
| 111 | MP0005409_darkened_coat_color | 0.35514992 |
| 112 | MP0002078_abnormal_glucose_homeostasis | 0.35431591 |
| 113 | MP0003566_abnormal_cell_adhesion | 0.35117636 |
| 114 | MP0000371_diluted_coat_color | 0.34908509 |
| 115 | MP0004484_altered_response_of | 0.34744785 |
| 116 | MP0000013_abnormal_adipose_tissue | 0.34573972 |
| 117 | MP0001501_abnormal_sleep_pattern | 0.33781028 |
| 118 | MP0003221_abnormal_cardiomyocyte_apopto | 0.33603596 |
| 119 | MP0001663_abnormal_digestive_system | 0.33492142 |
| 120 | MP0001485_abnormal_pinna_reflex | 0.33154083 |
| 121 | MP0001879_abnormal_lymphatic_vessel | 0.32384366 |
| 122 | MP0009703_decreased_birth_body | 0.31307538 |
| 123 | MP0008775_abnormal_heart_ventricle | 0.31050492 |
| 124 | MP0006035_abnormal_mitochondrial_morpho | 0.30752526 |
| 125 | MP0003690_abnormal_glial_cell | 0.27780776 |
| 126 | MP0000003_abnormal_adipose_tissue | 0.27055093 |
| 127 | MP0003868_abnormal_feces_composition | 0.23111679 |
| 128 | MP0008569_lethality_at_weaning | 0.21945371 |
| 129 | MP0003011_delayed_dark_adaptation | 0.21912605 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Metabolic alkalosis (HP:0200114) | 8.95914529 |
| 2 | Hypokalemic alkalosis (HP:0001949) | 8.82450527 |
| 3 | Increased circulating renin level (HP:0000848) | 8.62212637 |
| 4 | Hyperactive renin-angiotensin system (HP:0000841) | 7.93621328 |
| 5 | Hypomagnesemia (HP:0002917) | 7.65486166 |
| 6 | Polyuria (HP:0000103) | 7.57321737 |
| 7 | Abnormality of chloride homeostasis (HP:0011422) | 7.51043824 |
| 8 | Abnormal urine output (HP:0012590) | 7.06301817 |
| 9 | Abnormality of renal excretion (HP:0011036) | 6.53070396 |
| 10 | Abnormality of magnesium homeostasis (HP:0004921) | 6.50401362 |
| 11 | Gout (HP:0001997) | 6.37882895 |
| 12 | Tetany (HP:0001281) | 6.16234689 |
| 13 | Renal salt wasting (HP:0000127) | 6.02240757 |
| 14 | Abnormal drinking behavior (HP:0030082) | 6.01800721 |
| 15 | Polydipsia (HP:0001959) | 6.01800721 |
| 16 | Hyperaldosteronism (HP:0000859) | 5.89397625 |
| 17 | Alkalosis (HP:0001948) | 5.43863017 |
| 18 | Abnormality of renin-angiotensin system (HP:0000847) | 5.40784526 |
| 19 | Hyperuricemia (HP:0002149) | 4.57966461 |
| 20 | Increased purine levels (HP:0004368) | 4.57966461 |
| 21 | Proximal tubulopathy (HP:0000114) | 4.46361885 |
| 22 | Hypokalemia (HP:0002900) | 4.37420223 |
| 23 | Hypercalciuria (HP:0002150) | 3.99580406 |
| 24 | Hyperglycinuria (HP:0003108) | 3.94608901 |
| 25 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.83999184 |
| 26 | Abnormality of purine metabolism (HP:0004352) | 3.82449577 |
| 27 | Abnormality of potassium homeostasis (HP:0011042) | 3.58698238 |
| 28 | Generalized aminoaciduria (HP:0002909) | 3.23324034 |
| 29 | Abnormality of glycine metabolism (HP:0010895) | 3.19654650 |
| 30 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.19654650 |
| 31 | Renal tubular acidosis (HP:0001947) | 3.17588478 |
| 32 | Abnormality of sodium homeostasis (HP:0010931) | 3.16867275 |
| 33 | Large eyes (HP:0001090) | 3.16204636 |
| 34 | Ketoacidosis (HP:0001993) | 3.09289644 |
| 35 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.00603693 |
| 36 | Hyponatremia (HP:0002902) | 2.90661889 |
| 37 | Glycosuria (HP:0003076) | 2.89808257 |
| 38 | Abnormality of urine glucose concentration (HP:0011016) | 2.89808257 |
| 39 | Nephrocalcinosis (HP:0000121) | 2.88614819 |
| 40 | Adrenal overactivity (HP:0002717) | 2.80490111 |
| 41 | Abnormality of nucleobase metabolism (HP:0010932) | 2.73053631 |
| 42 | Dehydration (HP:0001944) | 2.68075701 |
| 43 | Ketosis (HP:0001946) | 2.62928728 |
| 44 | Abnormality of proline metabolism (HP:0010907) | 2.54694549 |
| 45 | Hydroxyprolinuria (HP:0003080) | 2.54694549 |
| 46 | Hyperphosphaturia (HP:0003109) | 2.50622166 |
| 47 | Delayed epiphyseal ossification (HP:0002663) | 2.44447978 |
| 48 | Abnormal urine phosphate concentration (HP:0012599) | 2.39412047 |
| 49 | Nephrolithiasis (HP:0000787) | 2.35628297 |
| 50 | Chondrocalcinosis (HP:0000934) | 2.32788033 |
| 51 | Tubulointerstitial fibrosis (HP:0005576) | 2.30561480 |
| 52 | Facial shape deformation (HP:0011334) | 2.29464542 |
| 53 | Potter facies (HP:0002009) | 2.29464542 |
| 54 | Delayed CNS myelination (HP:0002188) | 2.27532583 |
| 55 | Abnormality of Sharpey fibers (HP:0100685) | 2.18223316 |
| 56 | Decreased circulating renin level (HP:0003351) | 2.18035094 |
| 57 | Tubular atrophy (HP:0000092) | 2.17741506 |
| 58 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.13231627 |
| 59 | Hyperglycinemia (HP:0002154) | 2.12884578 |
| 60 | Hypophosphatemia (HP:0002148) | 2.12406985 |
| 61 | Metaphyseal cupping (HP:0003021) | 2.10936436 |
| 62 | Vomiting (HP:0002013) | 2.10824392 |
| 63 | Focal segmental glomerulosclerosis (HP:0000097) | 2.07277151 |
| 64 | Thyroid-stimulating hormone excess (HP:0002925) | 2.04972824 |
| 65 | Vascular calcification (HP:0004934) | 2.03787148 |
| 66 | Rickets (HP:0002748) | 2.00434737 |
| 67 | Vacuolated lymphocytes (HP:0001922) | 1.99543459 |
| 68 | Hypotension (HP:0002615) | 1.96041556 |
| 69 | Glomerulosclerosis (HP:0000096) | 1.95926452 |
| 70 | Hyperammonemia (HP:0001987) | 1.95768088 |
| 71 | Enlarged kidneys (HP:0000105) | 1.93787323 |
| 72 | Widely patent fontanelles and sutures (HP:0004492) | 1.90762657 |
| 73 | Generalized muscle weakness (HP:0003324) | 1.90221360 |
| 74 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.88755441 |
| 75 | Dicarboxylic aciduria (HP:0003215) | 1.88755441 |
| 76 | Renal tubular dysfunction (HP:0000124) | 1.86070571 |
| 77 | Abnormal platelet function (HP:0011869) | 1.85760318 |
| 78 | Impaired platelet aggregation (HP:0003540) | 1.85760318 |
| 79 | Hypothermia (HP:0002045) | 1.84200248 |
| 80 | Metabolic acidosis (HP:0001942) | 1.84103231 |
| 81 | Cardiovascular calcification (HP:0011915) | 1.81379536 |
| 82 | Bicornuate uterus (HP:0000813) | 1.80941278 |
| 83 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.79558819 |
| 84 | Abnormality of renal resorption (HP:0011038) | 1.77339123 |
| 85 | Thin bony cortex (HP:0002753) | 1.74838434 |
| 86 | Lymphangioma (HP:0100764) | 1.74705637 |
| 87 | Malnutrition (HP:0004395) | 1.73827703 |
| 88 | Neonatal onset (HP:0003623) | 1.69184705 |
| 89 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.66976514 |
| 90 | Lethargy (HP:0001254) | 1.66460056 |
| 91 | Confusion (HP:0001289) | 1.63763174 |
| 92 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.62823229 |
| 93 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.61948712 |
| 94 | Irritability (HP:0000737) | 1.57239973 |
| 95 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.57212925 |
| 96 | Methylmalonic aciduria (HP:0012120) | 1.56807895 |
| 97 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.56118824 |
| 98 | Hyperkalemia (HP:0002153) | 1.55079202 |
| 99 | Abnormal tarsal ossification (HP:0008369) | 1.50840418 |
| 100 | Goiter (HP:0000853) | 1.48218344 |
| 101 | Tachypnea (HP:0002789) | 1.45263957 |
| 102 | Tubulointerstitial abnormality (HP:0001969) | 1.43998151 |
| 103 | Abnormality of the costochondral junction (HP:0000919) | 1.41815671 |
| 104 | Abnormality of the renal cortex (HP:0011035) | 1.41649865 |
| 105 | Metaphyseal irregularity (HP:0003025) | 1.40459037 |
| 106 | Nausea (HP:0002018) | 1.40251829 |
| 107 | Premature birth (HP:0001622) | 1.39910005 |
| 108 | Osteopenia (HP:0000938) | 1.33400793 |
| 109 | Elevated alkaline phosphatase (HP:0003155) | 1.23042371 |
| 110 | Neonatal death (HP:0003811) | 1.19617950 |
| 111 | Paresthesia (HP:0003401) | 1.18998570 |
| 112 | Nephrogenic diabetes insipidus (HP:0009806) | 1.17138806 |
| 113 | Abnormality of the renal medulla (HP:0100957) | 1.16281638 |
| 114 | Hypophosphatemic rickets (HP:0004912) | 1.13676321 |
| 115 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.13040090 |
| 116 | Metaphyseal dysplasia (HP:0100255) | 1.10664624 |
| 117 | Small for gestational age (HP:0001518) | 1.05082780 |
| 118 | Polyhydramnios (HP:0001561) | 1.02346448 |
| 119 | Osteomalacia (HP:0002749) | 0.97541123 |
| 120 | Esophageal varix (HP:0002040) | 0.96250778 |
| 121 | Abnormality of macular pigmentation (HP:0008002) | 0.94785932 |
| 122 | Abnormality of carpal bone ossification (HP:0006257) | 0.94373220 |
| 123 | Abnormality of cochlea (HP:0000375) | 0.92255372 |
| 124 | Intellectual disability, moderate (HP:0002342) | 0.92245756 |
| 125 | Nuclear cataract (HP:0100018) | 0.88839822 |
| 126 | Chorioretinal atrophy (HP:0000533) | 0.88525140 |
| 127 | Choanal stenosis (HP:0000452) | 0.83913710 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK3 | 9.66675120 |
| 2 | WNK4 | 8.27540915 |
| 3 | OXSR1 | 7.77242210 |
| 4 | STK39 | 3.95227425 |
| 5 | BCKDK | 2.41691772 |
| 6 | STK38L | 2.05211582 |
| 7 | SGK223 | 1.93324034 |
| 8 | SGK494 | 1.93324034 |
| 9 | WNK1 | 1.75564956 |
| 10 | PDK4 | 1.64883485 |
| 11 | PDK3 | 1.64883485 |
| 12 | NEK1 | 1.63615748 |
| 13 | MST4 | 1.38240075 |
| 14 | SGK2 | 1.35652768 |
| 15 | SGK3 | 1.24158821 |
| 16 | PDK2 | 1.21521614 |
| 17 | STK38 | 1.08060059 |
| 18 | MST1R | 1.07270853 |
| 19 | LRRK2 | 1.02241787 |
| 20 | PAK4 | 0.75586192 |
| 21 | EPHB1 | 0.71730398 |
| 22 | TIE1 | 0.70683896 |
| 23 | FRK | 0.68801114 |
| 24 | FGFR4 | 0.68294561 |
| 25 | TRIB3 | 0.66782552 |
| 26 | TGFBR2 | 0.61177705 |
| 27 | GSK3A | 0.60606219 |
| 28 | ERN1 | 0.57846867 |
| 29 | SGK1 | 0.56674637 |
| 30 | PTK2 | 0.56630398 |
| 31 | MAP2K6 | 0.54941102 |
| 32 | PTK6 | 0.53358514 |
| 33 | MAP3K3 | 0.52527372 |
| 34 | EPHA2 | 0.48185599 |
| 35 | STK10 | 0.47702719 |
| 36 | PINK1 | 0.47486965 |
| 37 | FER | 0.44763692 |
| 38 | MAP3K7 | 0.44294761 |
| 39 | GRK6 | 0.43700023 |
| 40 | PRKAA1 | 0.42478765 |
| 41 | DYRK1B | 0.39398925 |
| 42 | PAK3 | 0.38578871 |
| 43 | PRKCI | 0.38475984 |
| 44 | FGFR3 | 0.37837171 |
| 45 | MET | 0.36731730 |
| 46 | AKT3 | 0.36716087 |
| 47 | PDPK1 | 0.32058729 |
| 48 | MYLK | 0.31236697 |
| 49 | RIPK1 | 0.30361306 |
| 50 | ABL2 | 0.28278518 |
| 51 | NTRK1 | 0.26808906 |
| 52 | LATS1 | 0.26615793 |
| 53 | PRKD2 | 0.25876692 |
| 54 | MAP3K2 | 0.24844505 |
| 55 | EEF2K | 0.24808261 |
| 56 | PTK2B | 0.24664074 |
| 57 | CDK12 | 0.23487381 |
| 58 | PRKCZ | 0.23065390 |
| 59 | PRKAA2 | 0.22056831 |
| 60 | MAPK11 | 0.21337863 |
| 61 | RET | 0.20632769 |
| 62 | MAPK15 | 0.19135979 |
| 63 | EPHB2 | 0.18637906 |
| 64 | BMX | 0.17728623 |
| 65 | PRKCD | 0.17654183 |
| 66 | PDK1 | 0.16701373 |
| 67 | INSRR | 0.14965065 |
| 68 | NTRK3 | 0.14210613 |
| 69 | PRKACG | 0.13907573 |
| 70 | ICK | 0.13835382 |
| 71 | PDGFRA | 0.13149159 |
| 72 | PRKCH | 0.13137689 |
| 73 | AKT2 | 0.12574199 |
| 74 | MAPKAPK3 | 0.12088925 |
| 75 | PIK3CG | 0.11469021 |
| 76 | MAP2K2 | 0.10413022 |
| 77 | ERBB4 | 0.10087768 |
| 78 | NEK9 | 0.10061452 |
| 79 | MAP2K3 | 0.09781203 |
| 80 | KSR2 | 0.09198550 |
| 81 | PKN2 | 0.09041785 |
| 82 | CSNK1A1 | 0.09016758 |
| 83 | LMTK2 | 0.08720585 |
| 84 | ROCK1 | 0.08698888 |
| 85 | PRKACA | 0.08347925 |
| 86 | LATS2 | 0.08137935 |
| 87 | SCYL2 | 0.08134311 |
| 88 | MARK3 | 0.07694642 |
| 89 | CDC42BPA | 0.07556112 |
| 90 | PRKCA | 0.07148191 |
| 91 | TTN | 0.07078060 |
| 92 | PIK3CA | 0.06966029 |
| 93 | JAK2 | 0.06651640 |
| 94 | MAP3K14 | 0.06444158 |
| 95 | SRC | 0.06141454 |
| 96 | STK11 | 0.05901644 |
| 97 | CDK6 | 0.05586429 |
| 98 | MAP2K1 | 0.05320262 |
| 99 | INSR | 0.04543447 |
| 100 | MAP3K11 | 0.04431331 |
| 101 | DDR2 | 0.03928894 |
| 102 | MAP3K1 | 0.03655310 |
| 103 | DAPK2 | 0.03420948 |
| 104 | FGFR2 | 0.03051955 |
| 105 | MINK1 | 0.02732343 |
| 106 | PIM1 | 0.02493702 |
| 107 | RPS6KA3 | 0.02314591 |
| 108 | MTOR | 0.02311415 |
| 109 | TESK1 | 0.02100154 |
| 110 | SIK1 | 0.01437504 |
| 111 | MAP3K8 | 0.01057335 |
| 112 | KDR | 0.01034643 |
| 113 | PRKCB | 0.00934491 |
| 114 | TGFBR1 | 0.00857569 |
| 115 | CSF1R | 0.00795525 |
| 116 | IRAK2 | 0.00181306 |
| 117 | EPHA3 | 0.00064313 |
| 118 | MAPK3 | -0.0430676 |
| 119 | MAPK4 | -0.0396721 |
| 120 | PRKD1 | -0.0393415 |
| 121 | TYRO3 | -0.0351661 |
| 122 | MAPK8 | -0.0243570 |
| 123 | PRKCQ | -0.0210028 |
| 124 | RPS6KA2 | -0.0205776 |
| 125 | NLK | -0.0199145 |
| 126 | DMPK | -0.0196566 |
| 127 | TRPM7 | -0.0163804 |
| 128 | IGF1R | -0.0157297 |
| 129 | NME1 | -0.0146858 |
| 130 | SMG1 | -0.0106752 |
| 131 | ROCK2 | -0.0042898 |
| 132 | MATK | -0.0036763 |
| 133 | FGFR1 | -0.0009104 |
| 134 | PRKCG | -0.0007619 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 3.98437840 |
| 2 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.41632390 |
| 3 | Butanoate metabolism_Homo sapiens_hsa00650 | 3.34779104 |
| 4 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.32014710 |
| 5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.17446545 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 3.16781557 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.16581675 |
| 8 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.16091620 |
| 9 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.93851710 |
| 10 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.80982451 |
| 11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.51182878 |
| 12 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.35166899 |
| 13 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.34679022 |
| 14 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.28286768 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.27030798 |
| 16 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.07883024 |
| 17 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.00928017 |
| 18 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.00298278 |
| 19 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.87876455 |
| 20 | Bile secretion_Homo sapiens_hsa04976 | 1.85269300 |
| 21 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.82237419 |
| 22 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.77681325 |
| 23 | Carbon metabolism_Homo sapiens_hsa01200 | 1.77320909 |
| 24 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.74255035 |
| 25 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.70026668 |
| 26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.67098552 |
| 27 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.64212663 |
| 28 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.60487307 |
| 29 | Mineral absorption_Homo sapiens_hsa04978 | 1.59694518 |
| 30 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.43373420 |
| 31 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.40243359 |
| 32 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.37364124 |
| 33 | Other glycan degradation_Homo sapiens_hsa00511 | 1.31758966 |
| 34 | Lysine degradation_Homo sapiens_hsa00310 | 1.22834320 |
| 35 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.22622817 |
| 36 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.19750486 |
| 37 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.19678817 |
| 38 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.18322003 |
| 39 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.15498395 |
| 40 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.10772959 |
| 41 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.08362307 |
| 42 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.07599440 |
| 43 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.99361233 |
| 44 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.96823325 |
| 45 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.94022480 |
| 46 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.93442107 |
| 47 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.89410531 |
| 48 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.89168885 |
| 49 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.84933254 |
| 50 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.83500932 |
| 51 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.80531933 |
| 52 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.79820846 |
| 53 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.79121266 |
| 54 | Endometrial cancer_Homo sapiens_hsa05213 | 0.77398374 |
| 55 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.77199878 |
| 56 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.77146072 |
| 57 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.75874140 |
| 58 | Lysosome_Homo sapiens_hsa04142 | 0.75474134 |
| 59 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.75362561 |
| 60 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.74570973 |
| 61 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.73518462 |
| 62 | Histidine metabolism_Homo sapiens_hsa00340 | 0.72378045 |
| 63 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.70350775 |
| 64 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.68131838 |
| 65 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.67826269 |
| 66 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.60460387 |
| 67 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.59389878 |
| 68 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58534237 |
| 69 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.55054323 |
| 70 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.51521719 |
| 71 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.51157810 |
| 72 | Parkinsons disease_Homo sapiens_hsa05012 | 0.47669811 |
| 73 | Thyroid cancer_Homo sapiens_hsa05216 | 0.46591107 |
| 74 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46464664 |
| 75 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.46076782 |
| 76 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.44883177 |
| 77 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.44697384 |
| 78 | Melanoma_Homo sapiens_hsa05218 | 0.43870184 |
| 79 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.42932460 |
| 80 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.40249301 |
| 81 | Glioma_Homo sapiens_hsa05214 | 0.39064539 |
| 82 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.38224662 |
| 83 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.36405304 |
| 84 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.33394361 |
| 85 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.31145714 |
| 86 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.29549020 |
| 87 | Retinol metabolism_Homo sapiens_hsa00830 | 0.28763668 |
| 88 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.25657876 |
| 89 | ABC transporters_Homo sapiens_hsa02010 | 0.22570123 |
| 90 | Circadian rhythm_Homo sapiens_hsa04710 | 0.22546954 |
| 91 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.22142751 |
| 92 | Bladder cancer_Homo sapiens_hsa05219 | 0.21032659 |
| 93 | Prostate cancer_Homo sapiens_hsa05215 | 0.20714063 |
| 94 | Sulfur relay system_Homo sapiens_hsa04122 | 0.20540283 |
| 95 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.20241407 |
| 96 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.20080164 |
| 97 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.19388127 |
| 98 | Alzheimers disease_Homo sapiens_hsa05010 | 0.19248691 |
| 99 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.18113664 |
| 100 | Gap junction_Homo sapiens_hsa04540 | 0.17864866 |
| 101 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.16129106 |
| 102 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.15965307 |
| 103 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.14887052 |
| 104 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.14645003 |
| 105 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.14330090 |
| 106 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.14174843 |
| 107 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.12400022 |
| 108 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.12080623 |
| 109 | Insulin resistance_Homo sapiens_hsa04931 | 0.11910567 |
| 110 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.10816911 |
| 111 | Tight junction_Homo sapiens_hsa04530 | 0.08893501 |
| 112 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.07847202 |
| 113 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.06046020 |
| 114 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.05693786 |
| 115 | Huntingtons disease_Homo sapiens_hsa05016 | 0.03887889 |
| 116 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.02713177 |
| 117 | Focal adhesion_Homo sapiens_hsa04510 | 0.01900231 |
| 118 | Hepatitis C_Homo sapiens_hsa05160 | 0.01225603 |
| 119 | Galactose metabolism_Homo sapiens_hsa00052 | -0.0040267 |
| 120 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.0031557 |

